Clinical ADR data for doctors/prescribers


DRUG SAFETY UPDATE FROM THE MHRA about erectile dysfunction and loss of libido linked to acne drug isotretinoin known as Roaccutane and many other generic names.

For Doctors and prescribers important information that may reduce iatrogenic illness and prevent further complications and a downward spiral in the health of your patient.

Current Drug regulator Safety Communications, 

Refer to updates on data about Adverse Reactions (ADRs) on the Electronic Medicines Compendium as for Losartan Potassium updated March 2018

FDA Warnings and Alerts Index to drug specific information

 MHRA general Drug safety updates issued by Medicines Healthcare Products Regulatory Agency 

More information for Prescribers here

For a quick check of possible neuropsychiatric adverse effects refer to :British Journal of Psychiatry Published bimonthly by The Royal College of Psychiatrists, 

BJPsych Advances offers a distillation of current clinical knowledge, written by expert clinicians to meet the CPD needs of consultant psychiatrists.

Nora Turjanski, Geoffrey G. Lloyd